MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Clinical trial NCT06541249 · RECRUITING

Trial details

NCT number: NCT06541249
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

Start date: 2024-10-02
Primary completion: 2027-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.